Latest news for GZ6G Technologies (OTC:GZIC) Stock

GZ6G Technologies Corp is a complete enterprise smart solutions provider. It is focused on acquiring smart city solutions, developing products, and overseeing smart cities and smart venues. It also assists in modernizing clients with wireless IoT technology for the emerging 5G and Wi-Fi 6 marketplaces. It generates revenue from contracts that among other services, provide wireless and digital promotion rights for certain events including WiFi media network advertising rights, and the development of smart venue wireless networks and software engagement technology products for airports, stadiums, campuses, cities, and other venues in the United States and International markets.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAWW

ABMD

ACTG

ADAP

ADGO

ADMS

AITA

ALPN

AMCR

AMTD

ANDE

ANGO

ANIOY

AOBC

APEX

APTY

APYI

ASTC

ASTI

Adtalem Global Education Inc. Common Stock

ATGE

AUPH

AVLIF

AVALON ADVANCED MAT ORD by Avalon Advanced Materials Inc.

AVLNF

AVTR

AVYA

AXAS

AXTI

BIOVF

BLIN

BLUE

BNED

BNFT

BORR

BOSSY

BRGGF

BSTC

BTCS

BTHCF

BYDDY

CANB

CCAN

CDEV

CELLCUBE ENERGY STORAGE by Cellcube Energy Storage Sys Inc.

CECBF

CEIX

CFWFF

CGTFF

CHAP

CHMJF

CHRA

CLLS

CMPNF

CHANGE FINANCIAL LTD by Change Financial Ltd.

CNGFF

COBALT BLOCKCHAIN INC by Cobalt Blockchain Inc.

COBCF

CPFXF

CREX

CRVS

CRZO

CSBR

CSLT

CTRA

CTRC

CWAFF

DDBXF

DFIN

DFMTF

DIIBF

DLNDY

DMPI

DPDW

DTIL

DYMEF

EBKOF

EEVVF

EINF

ENBL

EPAY

Embraer-Empresa Brasileira De Aeronautica

ETFC

EZPW

FANG

FDMSF

FLMN

FOXA

FRNKF

Stocks That Hit 52-Week Lows On Thursday

ADRO

AKCA

ANDR

ANGI

APWC

APYP

ARCH

AREX

ARTH

ASDZF

AVCRF

AXREF

BMNM

BNGO

CBIO

CCTC

CGNSF

CHFS

CHAKANA COPPER CORP by Chakana Copper Corp.

CHKKF

CLVS

CMVLF

CNPOF

CRXPF

DGTW

EMMA

FEWP

FPMI

FVANF

GLNNF

GZIC

HKRSQ

HNRG

INCC

IRIX

JAMN

KALV

KSHB

MFST

MMBF

MMNFF

MMRTY

MRBLF

MRSN

NBEV

NESR

NHMD

NVIV

ONTX

PCRTF

PHOT

PNEXF

POTN

PRQR

PTNYF

QBIO

RAVENQUEST BIOMED INC by Ravenquest Biomed Inc.

RVVQF

SANP

SGBX

SIOCF

SLGWF

SMGI

SNDL

SNNA

SOLCF

SPCB

SPHS

SRMLF

STMH

STSC

Swire Pacific Sponsored representing 1 Class A Share

SWRAY

TBEV

TBNGY

TCHH

TLLTF

TSNP

TWOH

UFMG

VEGYF

VRTHF

VVCIF

VXRT

WDRP

YTEN

MPEG

BLRDF

CNVAF

SNIRF

SNHPF

AINC

NEVDF

HLKMF

Stocks That Hit 52-Week Lows On Monday

GZ6G TECHNOLOGIES CORP by GZ6G Technologies Corp.

GZ6G Technologies Corp

Trial taking place at <a href="https://www.seha.ae/hospital-detail/1">Sheikh Khalifa Medical City</a>, a flagship tertiary hospital in the United Arab Emirates
POC data generated from this study could potentially lead to reimbursed early patient access in certain European countries for crofelemer for MVID
Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome with intestinal failure (SBS-IF)
SAN FRANCISCO, CA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / January 22, 2025 / <a href="https://pr.report/66fk">Jaguar Health, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) (Jaguar) family companies <a href="https://pr.report/66fm">Napo Pharmaceuticals</a> (Napo) and <a href="https://pr.report/66fn">Napo Therapeutics</a> today announced that the first patient has been dosed in the independent investigator-initiated POC trial of crofelemer, Jaguar's novel plant-based anti-diarrheal prescription drug, for the rare disease indication of MVID in pediatric patients. POC data generated from this study potentially in the first half of 2025 could lead to reimbursed early patient access to crofelemer for this indication in certain European countries.
The trial will also include pediatric patients with SBS-IF. It is being conducted by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology who is the Division Chief of the Pediatric Gastroenterology, Hepatology &amp; Nutrition Division at <a href="https://pr.report/66fo">Sheikh Khalifa Medical City</a> (SKMC), a flagship tertiary hospital in the UAE and the largest teaching medical center in Abu Dhabi.

Biotech

JAGX

Jaguar Health Announces First Patient Dosed In UAE POC Trial For Crofelemer In Pediatric MVID; Potential For Early Access In Europe By H1 2025; Drug Holds Orphan Designation For MVID And SBS-IF By FDA And EMA

First Community (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCCO#NASDAQ">FCCO</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.49 by 12.24 percent. This is a 27.91 percent increase over earnings of $0.43 per share from the same period last year.

First Community Q4 EPS $0.55 Beats $0.49 Estimate

Comments

GZ6G Technologies

News

Latest news for GZ6G Technologies (OTC:GZIC) Stock

Thursday, October 03, 2019

Monday, September 23, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga